H3 BIOMEDICINE
H3 Biomedicine is a privately held, uniquely structured oncology discovery enterprise. At H3, they seek to become a prolific source of new drugs that treat more human cancers with greater success. H3 Biomedicine is applying the expertise of leading scientists to the integration of insights from cancer genomics with innovative capabilities in synthetic chemistry and tumor biology to pursue patient-based, genomics-driven, small molecule drugs, which represent the most promising current opportunity in cancer therapeutics.
H3 BIOMEDICINE
Industry:
Biotechnology Genetics Medical
Founded:
2010-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.h3biomedicine.com
Total Employee:
51+
Status:
Active
Contact:
6172525098
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Domain Not Resolving Wordpress Plugins IPv6 Contact Form 7
Similar Organizations
Advanced Analytical Technologies
AATI develops, manufactures and markets high-throughput, fully-automated nucleic acid and genetic analysis systems.
Origin
Origin is a privately held, clinical-stage biotechnology company.
Affymetrix
Affymetrix now develops and provides innovative technologies that enable multiplex and parallel analysis of biological systems at the cell,
AIM Biotech
AIM Biotech offers a modular platform to co-culture multiple cell types in discrete 3D and 2D channels.
ArborGen
ArborGen grows and sells pine, eucalyptus and hardwood tree seedlings to the forestry industry.
BaseClear
BaseClear is a contract research laboratory for DNA-based analysis.
Biomatik Corporation
Biomatik Corporation is a full service life sciences products and services company.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Codex Genetics
Codex Genetics will first launch the Asian-specific personalized genetic analysis service: SEQ-Me.
Family Tree DNA
Family Tree DNA is a genetic genealogy-based company focused on Y chromosome, autosomal, and mitochondrial ancestry DNA testing.
Haystack Sciences
DNA-enabled medicines for the 21st century.
Switch Biotech AG
SWITCH Biotech uses its broad knowledge and expertise of the molecular biology of the skin to develop drugs for various skin disorders.
ViaGen
ViaGen, a division of Trans Ova Genetics is the industry’s premier source of cloning technology for all non-primate species.
Current Employees Featured
Founder
Official Site Inspections
http://www.h3biomedicine.com Semrush global rank: 1.51 M Semrush visits lastest month: 17.71 K
Unable to get host informations!!!
More informations about "H3 Biomedicine"
H3 Biomedicine - Crunchbase Company Profile
H3 Biomedicine is a privately held, uniquely structured oncology discovery enterprise. At H3, they seek to become a prolific source of new drugs that …See details»
SCOOP: Eisai closing oncology R&D wing H3 …
Jul 18, 2022 The work at H3 will now be shifted to Eisai’s Deep Human Biology Learning organization. H3 had been plowing ahead with four clinical-stage programs, including lead asset H3B-6545 in a phase 2 ...See details»
H3 Biomedicine Information - RocketReach
H3 Biomedicine is a privately held biopharmaceutical company focused on the discovery and early development of novel, targeted anti-cancer compounds for the unmet needs of …See details»
H3 Biomedicine Inc. - Cambridge, USA - bionity.com
May 27, 2014 H3 Biomedicine is a privately held biopharmaceutical company focused on the discovery and early development of novel, targeted anti-cancer compounds for the unmet …See details»
Eisai Announces New Executive Leadership Team at H3 …
WOODCLIFF LAKE, N.J., Aug. 30, 2021 /PRNewswire/ -- Eisai today announced that H3 Biomedicine (H3), its cancer genomics-based drug discovery subsidiary company located in Cambridge, Mass., has appointed a new executive …See details»
H3 Biomedicine Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for H3 Biomedicine Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
H3 Biomedicine - Org Chart, Teams, Culture & Jobs | The Org
View H3 Biomedicine's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
H3 Biomedicine Company Profile - Office Locations, Competitors
H3 Biomedicine. H3 Biomedicine Summary. Company Summary. Overview. H3 Biomedicine is a biopharmaceutical company that specializes in cancer genomics. It leverages tumor biology, …See details»
H3 Biomedicine | VentureRadar
H3 Biomedicine, the U.S.-based precision oncology research and development subsidiary of Eisai Co., Ltd., is focused on advancing drugs from bench to bedside. Uniquely positioned to …See details»
H3 Biomedicine, Inc. - Drug pipelines, Patents, Clinical trials
Explore H3 Biomedicine, Inc. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 10 news, and 45 literature, Disease Domain:Neoplasms ...See details»
Eisai shutters oncology venture H3—Fierce Pharma Asia
Jul 22, 2022 Eisai is shutting down its H3 Biomedicine oncology unit. H3 is laying off 88 people stationed there, and its work will be transferred to Eisai’s Deep Human Biology Learning …See details»
H3 Biomedicine Inc. Unveils New Headquarters and Laboratories in ...
Dec 1, 2011 H3 Biomedicine Inc. is a privately held, uniquely structured drug discovery enterprise that is integrating insights from cancer genomics with innovative capabilities in …See details»
H3 Biomedicine Launches to Discover and Develop Next …
Jan 27, 2011 H3 Biomedicine’s scientific founders are renowned researchers Stuart L. Schreiber, PhD, and Todd R. Golub, MD, who will serve as academic advisors to the company.See details»
Eisai Announces New Executive Leadership Team at H3 Biomedicine
Aug 30, 2021 About H3 Biomedicine Inc. H3 Biomedicine Inc., the U.S.-based precision oncology research and development subsidiary of Eisai Co., Ltd., is solely focused on …See details»
Our relentless pursuit of a world without cancer | Eisai US
Jan 31, 2025 Our scientists collaborate across functions while following a biology-first approach—and broadening our horizons allows us to consider the science behind more than …See details»
H3 Biomedicine-H3 Biomedicine, Inc.-企业详情-InvestGO数据库 …
Dec 31, 2009 查看医药魔方InvestGO®数据库H3 Biomedicine的公司信息。H3 Biomedicine（H3 Biomedicine, Inc.），公司简介：H3 Biomedicine is a privately held, uniquely structured …See details»
Bristol Myers Squibb - Bristol-Myers Squibb and H3 Biomedicine …
Dec 17, 2018 Bristol-Myers Squibb Company (NYSE: BMY), Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and its U.S.-based precision medicine research & …See details»
H3 Biomedicine Announces Expanded Use of Real-World Evidence …
Feb 11, 2021 About H3 Biomedicine Inc. H3 Biomedicine Inc., the U.S.-based precision oncology research and development subsidiary of Eisai Co., Ltd., is solely focused on …See details»
Foundation Medicine and H3 Biomedicine Announce …
Feb 24, 2015 H3 Biomedicine is a privately held biopharmaceutical company focused on the discovery and early development of novel, targeted anti-cancer compounds for the unmet …See details»
H3 Biomedicine, Inc. (H3 Biomedicine, Inc.) - 药物管线_专利_临床 …
了解H3 Biomedicine, Inc. (H3 Biomedicine, Inc.)公司的药物管线，治疗领域，技术平台，以及它的4项临床试验, 10篇新闻和45篇文献，疾病领域:肿瘤，技术平台:小分子化药，药物:H3B …See details»